Altamira Therapeutics’ Sale Of Majority Stake in Altamira Medica AG

Walder Wyss advised Nasdaq listed Altamira Therapeutics.Altamira Therapeutics Ltd. (Nasdaq: CYTO), a company dedicated to developing therapeutics that address important unmet medical needs, entered into a binding agreement…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Marco Zingaro

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here